Eventually, chronic diseases appear and our health suffers
SUSTAIN-6 (semaglutide) [53], PIONEER 6 (semaglutide) [61], and LEADER (liraglutide) [54] looked at similar patient populations (over 50 years old with established cardiovascular disease) and found that GLP-1RAs produce a cardiovascular protective function relative to primary endpoints (Table 1)
Patients should focus on nutrient-dense foods that support muscle function, digestion, energy levels, and long-term weight maintenance
doi: 10.3389/fmicb.2019.00027 Received 28 October 2018 Accepted 09 January 2019 Published 25 January 2019 Volume 10 - 2019 Edited by Dominique Sanglard, Universit de Lausanne, Switzerland Reviewed by Erika Shor, Public Health Research Institute (PHRI), United States
In a pure head-to-head about mechanism and long-range upside, retatrutide is the compound that currently feels more ambitious